Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Imaging Beta-amyloid in Middle Age Alcoholics As a Mechanism That Increases Their Risk for Alzheimer's Disease

NCT03746366 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT03746366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03746366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Imaging Beta-amyloid in Middle Age Alcoholics As a Mechanism That Increases Their Risk for Alzheimer's Disease
Lead sponsor
University of Pittsburgh
Phase
Phase 1
Overall status
Completed
Start date
December 1, 2018
Completion date
July 1, 2020
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder